The truth about glutathione — what is proven, what isn't, and what the authorities have warned about

Glutathione is among the most searched-for substances in the wellness space in Romania, and among those about which the most unverified things are written. This article separates what is known from what is hoped for.

What it is, without the marketing

A tripeptide made up of glutamic acid, cysteine and glycine, produced by the body and present in almost all cells. Its recognised role:

• it is the main antioxidant inside the cell — it neutralises reactive oxygen species;
• it takes part in liver detoxification, in the second phase of metabolism, where it helps conjugate certain substances for elimination;
• it is involved in recycling other antioxidants, including vitamin C and vitamin E.

All of this is established biochemistry. It is not in question.

"The most powerful antioxidant": what it means, biochemically

The phrase appears on almost every page about glutathione — "the most powerful antioxidant", "the ultimate antioxidant", "master antioxidant". It is worth taking apart, because part of it is true and part of it is just rhetoric.

The true part. The specialist literature describes glutathione as the most abundant non-protein thiol in mammalian tissues and the most abundant antioxidant produced by the body. It works in two main ways:

• it neutralises oxidants by reduction — the reduced form (GSH) gives up electrons and becomes the oxidised form (GSSG);
• it binds to toxic electrophilic substances (conjugation), which can then be eliminated.

The ratio between the oxidised and the reduced form is used in studies as a marker of oxidative stress: a fall in the proportion of GSSG is interpreted as a reduction in oxidative stress.

The part that is just rhetoric. "The most abundant" and "a central role" do not mean "the most powerful" in any sense that matters to you. What the literature describes is abundance and position in the antioxidant network, not a ranking of power according to which extra glutathione would do more good than anything else. And a detail that changes the perspective. The body produces its own glutathione, in the cytoplasm of cells, in a tightly regulated way. The factors that determine how much is produced are the availability of cysteine — the sulphur-containing amino acid in its structure — and the activity of a rate-limiting enzyme, glutamate-cysteine ligase. In other words, the level of glutathione in the cell is not a passive reservoir that you fill from outside, but a variable that the body actively controls. This is also where the interest in N-acetylcysteine, which supplies cysteine, comes from: NAC or glutathione.

Where the gap begins

The fact that a molecule has a role in the cell does not automatically mean that giving extra of it produces a measurable benefit in a healthy person. Between "takes part in liver detoxification" and "detoxifies your liver" lies exactly the distance that marketing covers without mentioning it.

What can honestly be said about supplementary administration:

• Blood levels rise after intravenous administration. This is measured and clear.
• What happens next — whether the rise translates into clinical effects in a person without a specific condition — is much less clear.
• There are medical contexts in which glutathione is studied seriously: chemotherapy-induced neuropathy, some liver conditions, Parkinson's disease. These are clinical situations, with diagnosed patients.

Why an important antioxidant does not automatically become a useful supplement

The idea that "if it's an antioxidant, more is better" has been tested on a large scale — not with glutathione, but with the classic antioxidants. A 2012 Cochrane review brought together 78 randomised trials, with almost 300,000 participants, in which beta-carotene, vitamin A, vitamin C, vitamin E and selenium were given. The authors' conclusion: they found no evidence to support antioxidant supplements for prevention, and beta-carotene and vitamin E even appeared to increase mortality.

Glutathione was not included in that review, so the conclusion does not apply to it directly. But the methodological lesson does: a real biological role does not guarantee an effect from supplementation. That has to be demonstrated separately, for each substance.

What studies done with glutathione itself have shown

When you look at the direct studies, the picture is more nuanced than "it works" or "it doesn't work":

And in chemotherapy-induced neuropathy — one of the indications for which injectable glutathione appears in manufacturers' materials — the guideline of the American Society of Clinical Oncology, updated in 2020, reconfirmed that no agent is recommended for prevention.

In short: glutathione can be raised in the body by certain routes, and intravenous administration was well tolerated in small studies. What is missing is proof of a clinical benefit in healthy people.

What is established, what is uncertain, what is unproven

The uncomfortable part: skin whitening

Here something has to be said that is not in our commercial interest.

The most popular use of intravenous glutathione worldwide is not detoxification — it is skin whitening. And on this use, the authorities have issued explicit warnings:

• In April 2018, the US authority published a warning that injectable skin-whitening products may be unsafe, based on the lack of safety evidence and on the fact that this use is not approved.
• In February 2019, the same authority reported seven patients with adverse reactions after improperly prepared injectable glutathione, caused by high levels of endotoxins.
• The authority in the Philippines, a country where the practice is widespread, issued a dedicated advisory on the unsafe use of glutathione as a whitening agent.

Specialist reviews point in the same direction: published clinical studies on injectable glutathione for skin whitening are very few and do not show a demonstrated effect, and the risks mentioned include anaphylactic reactions, liver damage and a lack of standardised dosing protocols.

We do not give glutathione for skin whitening and we do not present it as a cosmetic treatment.

What this means in practice

Glutathione is not a con and it is not a miracle. It is a molecule with a real role, with studied medical uses, and with a halo of promises that have no backing.

The right questions, if you are considering an IV drip:

What exactly is it for? If the answer is "to feel better, in general", the conversation starts with an assessment, not with a protocol.

What, concretely, is expected? A doctor who promises nothing measurable is more trustworthy than one who does.

Where is it given? Intravenous means medical staff present and equipment for a reaction — not a beauty salon.

How we work

We give intravenous glutathione, 600 or 1200 mg, at the clinic or at home, after a medical assessment, within our "detox and cellular protection" protocol category. We do not promise skin whitening, rejuvenation or the elimination of toxins.

In concrete terms: Glutathione 600 mg takes about 30 minutes and costs 250 RON; Glutathione 1200 mg takes about 45 minutes and costs 400 RON. For a series there are courses of 4 sessions: 750 RON for 600 mg, 1,200 RON for 1200 mg. The medical assessment is included, and the number of sessions is discussed at the assessment — there is no "proven" number of sessions for a healthy person.

The comparison with oral forms: liposomal or injectable glutathione. What's going on with the ampoules sold in online shops: TAD 600 and glutathione in ampoules. The protocol and prices: injectable glutathione.

Sources

Philippine FDA — Advisory on the unsafe use of glutathione as a skin-lightening agent.

Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review — a review of the evidence and the risks.

Alzahrani et al., Cureus, 2025 — the PubMed record of the same review as item 2: with intravenous administration, risks of anaphylaxis and liver toxicity and a lack of standardised dosing protocols.

Lu, Biochimica et Biophysica Acta, 2013 — glutathione synthesis: the most abundant non-protein thiol, regulation by cysteine and glutamate-cysteine ligase.

Forman et al., Molecular Aspects of Medicine, 2009 — the protective roles of glutathione: reduction of oxidants and conjugation of electrophiles.

Bjelakovic et al., Cochrane Database of Systematic Reviews, 2012 — antioxidant supplements and mortality, 78 randomised trials.

Witschi et al., European Journal of Clinical Pharmacology, 1992 — the systemic availability of oral glutathione, single dose.

Allen et al., Journal of Alternative and Complementary Medicine, 2011 — oral glutathione for 4 weeks, no effect on markers of oxidative stress.

Richie et al., European Journal of Nutrition, 2015 — oral glutathione for 6 months, randomised placebo-controlled trial.

Hauser et al., Movement Disorders, 2009 — intravenous glutathione, randomised pilot study.

Loprinzi et al., Journal of Clinical Oncology, 2020 — the ASCO guideline on the prevention and management of chemotherapy-induced neuropathy.

An informative article. It does not replace a medical consultation; any intravenous administration is decided by a doctor, after an assessment.